Do pharmacogenomic tests provide value to policy makers?
Shih
Ya-Chen Tina
YC
Pusztai
Lajos
L
D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006801:Humans; D010597:Pharmacogenetics / Q000191:economics* / Q000331:legislation & jurisprudence*; D019057:Quality-Adjusted Life Years